ω-3 fatty acids, atherosclerosis progression and cardiovascular outcomes in recent trials: New pieces in a complex puzzle

Heart

Volumn 100, Issue 7, 2014, Pages 530-533

  Wu, Jason H Y ^a   Mozaffarian, Dariush ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FISH OIL; OMEGA 3 FATTY ACID;

ATHEROSCLEROSIS; BLOOD LEVEL; CARDIOVASCULAR RISK; CLINICAL EFFECTIVENESS; CORONARY ARTERY CALCIFICATION; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; DOSE RESPONSE; DRUG DOSE INCREASE; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; ETHNIC DIFFERENCE; HEART DEATH; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART VENTRICLE FIBRILLATION; HUMAN; INCIDENCE; JAPANESE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SECONDARY PREVENTION; UNITED STATES;

CORONARY ARTERY DISEASE;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASES; DISEASE PROGRESSION; FATTY ACIDS, OMEGA-3; HUMANS;

EID: 84896548495     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2013-305257     Document Type: Review

References (29)

1. Rizos EC, Ntzani EE, Bika E, et al. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis. JAMA 2012;308:1024-33.
2. Roncaglioni MC, Tombesi M, Avanzini F, et al. N-3 fatty acids in patients with multiple cardiovascular risk factors. N Engl J Med 2013;368:1800-8.
3. Sekikawa A, Miura K, Lee S, et al. Long-chain n-3 polyunsaturated fatty acids and incidence rate of coronary artery calcification in japanese in japan and united states whites-population-based prospective cohort study. Heart 2014;100:569-73.
4. Mozaffarian D, Wu JH. Omega-3 fatty acids and cardiovascular disease-effects on risk factors, molecular pathways, and clinical events. J Am Coll Cardiol 2011;58:2047-67.
5. Wang Q, Liang X, Wang L, et al. Effect of omega-3 fatty acids supplementation on endothelial function: A meta-analysis of randomized controlled trials. Atherosclerosis 2012;221:536-43.
6. Wu JH, Cahill LE, Mozaffarian D. Effect of fish oil on circulating adiponectin: a systematic review and meta-analysis of randomized controlled trials. J Clin Endocrinol Metab 2013;98:2451-9.
7. Xin W, Wei W, Li X. Effects of fish oil supplementation on cardiac function in chronic heart failure: a meta-analysis of randomised controlled trials. Heart 2012;98:1620-5.
8. Yang Y, Lu N, Chen D, et al. Effects of n-3 pufa supplementation on plasma soluble adhesion molecules: a meta-analysis of randomized controlled trials. Am J Clin Nutr 2012;95:972-80.
9. Peoples GE, McLennan PL, Howe PR, et al. Fish oil reduces heart rate and oxygen consumption during exercise. J Cardiovasc Pharmacol 2008;52:540-7.
10. Albert CM. Omega-3 fatty acids, ventricular arrhythmias, and sudden cardiac death: antiarrhythmic, proarrhythmic, or neither. Circ Arrhythmia Electrophysiol 2012;5:456-9.
11. Mozaffarian D, Lemaitre RN, King IB, et al. Plasma phospholipid long-chain omega-3 fatty acids and total and cause-specific mortality in older adults: a cohort study. Ann Intern Med 2013;158:515-25.
12. Harris WS, Mozaffarian D, Lefevre M, et al. Towards establishing dietary reference intakes for eicosapentaenoic and docosahexaenoic acids. J Nutr 2009;139:804S-19S.
13. Marchioli R, Marfisi RM, Borrelli G, et al. Efficacy of n-3 polyunsaturated fatty acids according to clinical characteristics of patients with recent myocardial infarction: insights from the gissi-prevenzione trial. J Cardiovasc Med (Hagerstown) 2007;8(Suppl 1): S34-37. (Pubitemid 47429080)
14. Bosch J, Gerstein HC, Dagenais GR, et al. N-3 fatty acids and cardiovascular outcomes in patients with dysglycemia. N Engl J Med 2012;367:309-18.
15. Kim HJ, Giovannucci E, Rosner B, et al. Longitudinal and secular trends in dietary supplement use: Nurses' health study and health professionals follow-up study, 1986-2006. J Acad Nutr Diet 2013.
16. Adams J, Sibbritt D, Lui CW, et al. {omega}-3 fatty acid supplement use in the 45 and up study cohort. BMJ Open 2013;3:4.
17. Perrin AE, Simon C, Hedelin G, et al. Ten-year trends of dietary intake in a middle-aged french population: Relationship with educational level. Eur J Clin Nutr 2002;56:393-401. (Pubitemid 34520846)
18. Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA 2006;296:1885-99. (Pubitemid 44596197)
19. Djousse L, Akinkuolie AO, Wu JH, et al. Fish consumption, omega-3 fatty acids and risk of heart failure: A meta-analysis. Clin Nutr 2012;31:846-53.
20. Wu JH, Lemaitre RN, King IB, et al. Association of plasma phospholipid long-chain omega-3 fatty acids with incident atrial fibrillation in older adults: the cardiovascular health study. Circulation 2012;125:1084-93.
21. U.S. Department of agriculture and U.S. Department of health and human services. Dietary guidelines for americans. 7th edn. Washington, DC: U.S. Government Printing Office, 2010.
22. Burr ML, Fehily AM, Gilbert JF, et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (dart). Lancet 1989;2:757-61. (Pubitemid 19234807)
23. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin e after myocardial infarction: results of the gissi-prevenzione trial. Gruppo italiano per lo studio della sopravvivenza nell'infarto miocardico. Lancet 1999;354: 447-55.
24. Burr ML, Ashfield-Watt PA, Dunstan FD, et al. Lack of benefit of dietary advice to men with angina: results of a controlled trial. Eur J Clin Nutr 2003;57:193-200. (Pubitemid 36240469)
25. Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (jelis): a randomised open-label, blinded endpoint analysis. Lancet 2007;369:1090-8. (Pubitemid 46483662)
26. Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the gissi-hf trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008;372:1223-30.
27. Kromhout D, Giltay EJ, Geleijnse JM. N-3 fatty acids and cardiovascular events after myocardial infarction. N Engl J Med 2010;363:2015-26.
28. Rauch B, Schiele R, Schneider S, et al. Omega, a randomized, placebo-controlled trial to test the effect of highly purified omega-3 fatty acids on top of modern guideline-adjusted therapy after myocardial infarction. Circulation 2010;122:2152-9.
29. Galan P, Kesse-Guyot E, Czernichow S, et al. Effects of b vitamins and omega 3 fatty acids on cardiovascular diseases: a randomised placebo controlled trial. BMJ 2010;341:c6273.